Cantex Pharma’s Azeliragon Therapy: A Potential Cancer Breakthrough
In this interview, Dr. Stephen Marcus, CEO of Cantex Pharmaceuticals, discusses the innovative cancer therapy, Azeliragon. He explores its...
Unlocking New Digital Health Technology in Clinical Trials
In the rapidly evolving landscape of digital health technology in clinical trials (DHT), Jeremy Wyatt, CEO of ActiGraph, envisions...
AI-Driven Pathology: A New Era of Precision Clinical Trials
PathAI emerges as an enterprise transforming clinical trials with groundbreaking precision in the dynamic field of AI-driven pathology. Ben...
Clinical Trial Complexity: A Unique Challenge Tackled
As clinical trial complexity continues to rise, effective technology is paramount. In this interview, we discussed clinical trial technology...
Digital Twin Drug Development: The Future of Clinical Trials
In the fast-changing world of pharmaceutical drug development, new digital twin technologies are beginning to make a significant impact....
Digital Health Technologies: New Era in Clinical Research
Digital health technologies (DHTs) are revolutionizing the landscape of clinical research, pushing us toward more innovative and patient-centered trial...
Remarkable Edge in Cancer Vaccine Treatment: New Hope
In this interview, we engage with Andrew Allen, a pioneering force in the field of immunotherapy and the co-founder...
Unique Thyroid Cancer Tests: New Hope Unveiled
In the rapidly evolving landscape of medical research, particularly in the realm of cancer treatment, the development and application...
The Enhanced eConsent Evolution: A New Era for Trials
A groundbreaking proof-of-concept study conducted by Medable and the Duke BASE Lab unveiled electronic informed consent (eConsent) solutions in...
How To Overcome Large-Scale Clinical Trial EDC Migration
In an unprecedented move within the life sciences industry, Veeva announced the successful migration of 25 clinical studies for...